Optison Perflutren Protein-Type A Microspheres .22 mg/mL (Human Albumin Microspheres and Perflutren INJECTION, SOLUTION) .22 mg/mL

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is an injectable solution used for contrast enhancement in ultrasound imaging. This product, manufactured by GE Healthcare Inc., is designed to improve the visibility of blood flow and cardiac structures during diagnostic procedures.

Strength

.22 mg/mL

Pack Size

5 VIAL, SINGLE-USE in 1 CARTON (0407-2707-03) / 3 mL in 1 VIAL, SINGLE-USE

Manufacturer / TM Owner

GE Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is primarily used as a contrast agent in ultrasound imaging. It helps to enhance the visibility of blood flow and cardiac structures, making it easier for healthcare professionals to diagnose and monitor various conditions. This solution is administered intravenously and is commonly used in echocardiography to improve the clarity of images.

Side Effects

When administered, Optison Perflutren Protein-Type A Microspheres .22 mg/mL works by enhancing the reflection of ultrasound waves, which improves the quality of the images produced. This can lead to better visualization of blood flow and cardiac structures, aiding in more accurate diagnoses. The effects are typically temporary and related to the imaging procedure.

Precautions & Warnings

Optison Perflutren Protein-Type A Microspheres .22 mg/mL should be handled with care and administered by healthcare professionals. It is important to follow proper storage and handling guidelines to ensure the integrity of the solution. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Avoid Interactions

Optison Perflutren Protein-Type A Microspheres .22 mg/mL may interact with certain medications or medical conditions. It is important to discuss any current medications or health issues with a healthcare provider before use. Additionally, interactions with other contrast agents or imaging procedures should be considered.

Frequently Asked Questions

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is used as a contrast agent in ultrasound imaging to enhance the visibility of blood flow and cardiac structures.

Optison Perflutren Protein-Type A Microspheres .22 mg/mL is administered intravenously by healthcare professionals during ultrasound imaging procedures.

The common effects include enhanced reflection of ultrasound waves, leading to improved image quality and better visualization of blood flow and cardiac structures.

Yes, it should be handled and administered by healthcare professionals, and patients should inform their provider about any allergies or medical conditions.

Potential interactions with other medications or medical conditions should be discussed with a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.